Symposiums

Primary biliary cholangitis (PBC) often causes pruritus, impacting QoL. Validated patient-reported outcomes (PROs), such as PBC-40 an WI-NRS, can assess severity and aid management…

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 deaths…

This article summarises an Orchard Therapeutic-sponsored symposium titled ‘New horizons for metachromatic leukodystrophy – with the advent…

A distinguished panel of experts elaborated on different aspects of cardiovascular health in women receiving menopausal hormone therapy…

Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…

In many countries globally, ophthalmology clinics are over capacity, resulting in treatment delays and a reduction in the quality of…

This article has now been retracted and a retraction statement has been published.

Phase 2 randomised controlled trial (RCT) of BMS-986446, a monoclonal antibody targeting the tau microtubule binding region (MTBR)…